Two cancer immunotherapy makers face different situations in reimbursement talks

18 July 2019 - MSD returns to renegotiation table; BMS suffers from partner’s silence. ...

Read more →

Eli Lilly Korea gains further reimbursement for psoriasis treatment Taltz

1 July 2019 - The Korean branch of Eli Lilly said that it had gained additional reimbursement for its psoriasis ...

Read more →

Delayed patient access to innovative medical technologies in South Korea: a lead-time analysis of reimbursement coverage determinations

20 June 2019 - Timely access to innovative medical technologies driven by accelerated patient access pathways can substantially improve the health ...

Read more →

Role of health technology assessment in drug policies: Korea

13 June 2019 - South Korea is the first Asian country to mandate the submission of pharmacoeconomic data for reimbursement decision ...

Read more →

Pharmaceutical policy reforms to regulate drug prices in the Asia Pacific Region: the case of Australia, China, India, Malaysia, New Zealand, and South Korea

13 June 2019 - Medicine price directly affects affordability and access to medicines particularly in countries where a major portion of ...

Read more →

Atopic dermatitis patients demand reimbursement for Sanofi’s biological drug

12 June 2019 - Korean patients with severe atopic dermatitis gathered in front of the National Assembly on Tuesday to ...

Read more →

HIV prevention pill to get insurance benefit in Korea

30 May 2019 - The local medical community is likely to use a drug to prevent HIV infection in earnest.  ...

Read more →

Roche’s breast cancer drug gains more insurance benefits

21 May 2019 - The Ministry of Health and Welfare has granted additional reimbursement to Roche’s breast cancer therapy Perjeta (pertuzumab) ...

Read more →

Korean Government to reduce biopharmaceutical approval period to half

20 May 2019 - The Korean government plans to reduce by half the current one and a half years of ...

Read more →

Celgene’s myelodysplastic syndrome treatment gets more insurance benefits

7 May 2019 - The Ministry of Health and Welfare has granted additional reimbursement to Celgene’s multiple myeloma drug, Revlimid (ingredient: ...

Read more →

Roche agreed, MSD and BMS should, too

7 May 2019 - Immunotherapies have become so effective and popular that some cancer patients were cured. However, they are ...

Read more →

Biogen’s orphan drug Spinraza to get reimbursement

9 April 2019 - Biogen’s Spinraza (ingredient: nusinersen), a treatment for spinal muscular atrophy (SMA), started to receive insurance benefits as ...

Read more →

HIRA puts brakes on Gilead’s AIDS treatment receiving reimbursement

22 March 2019 - The reimbursement plan for Gilead Science Korea’s Biktarvy, an acquired immune deficiency syndrome (AIDS) treatment, has been ...

Read more →

Reimbursement for orphan drug Spinraza imminent

18 March 2019 - Biogen’s Spinraza (nusinersen), a treatment for spinal muscular atrophy, is likely to obtain reimbursement as early ...

Read more →

Korea’s 30th novel drug K-Cab to get insurance benefit from March

27 February 2019 - Korea’s 30th novel medicine K-Cab Tab. (tegoprazan) will receive insurance coverage, eight months after winning approval, the ...

Read more →